| Financial Year |
March 31 2023 |
| Monetary Funds |
139,253,859.84 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
27,490,057.95 |
| Accounts Receivable |
460,168,735.27 |
| Advances to Suppliers |
93,168,701.73 |
| Other Receivables |
7,091,967.49 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
467,407,507.01 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
41,359,094.09 |
| Total Current Assets |
1,510,676,575.08 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
528,705,584.23 |
| Under-construction Projects |
137,577,184.08 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
70,682,520.86 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
7,018,599.25 |
| Deferred Income Tax Assets |
25,309,511.49 |
| Other Non-Current Assets |
129,678,048.82 |
| Sub-Total of Non-Current Assets |
3,337,680,965.78 |
| Total Assets |
4,848,357,540.86 |
| Short-Term Loans |
117,524,044.60 |
| Trading Financial liabilities |
-- |
| Notes Payable |
129,131,814.72 |
| Accounts Payable |
489,140,017.75 |
| Accounts Received In Advance |
10,000.00 |
| Employee Compensation Payable |
12,460,032.59 |
| Taxes Payable |
7,272,227.59 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
121,780,470.60 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
71,207,645.07 |
| Other Current Liabilities |
17,486.73 |
| Sub-Total of Current Liabilities |
1,109,842,426.76 |
| Long-term Loans |
89,944,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
121,362,022.68 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
269,332,123.56 |
| Total Liabilities |
1,379,174,550.32 |
| Paid-In Capital(Or Share Stock) |
358,729,343.00 |
| Capital Surplus |
1,298,941,544.24 |
| Surplus Reserve |
141,851,063.12 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
794,211,542.65 |
| Minority Stockholder's Interest |
223,443,829.59 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,245,739,160.95 |
| Owner's Equity（Stockholder's Equity） |
3,469,182,990.54 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,848,357,540.86 |
